Ledger.Open graph →
SEC Form D · filed March 17, 2020

Lycia Therapeutics, Inc

Offering
$50.4M
Sold
$25.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Clare S. Ozawa · San Diego, CADirectorThomas S. Woiwode · San Diego, CADirectorLaurent S. Fischer · San Diego, CADirectorJeremy S. Caldwell · San Diego, CAExec · DirectorClare S. Ozawa · San Diego, CADirectorThomas S. Woiwode · San Diego, CADirectorLaurent S. Fischer · San Diego, CADirectorJeremy S. Caldwell · San Diego, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗